Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Hsin Chong Construction Group Limited : Major and Connected Transaction

03/22/2013 | 10:02am US/Eastern
Recommend:
0

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this joint announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this joint announcement.

HSIN CHONG CONSTRUCTION GROUP LTD.

*

(Incorporated in Bermuda with limited liability)

(Stock Code: 00404) MAJOR AND CONNECTED TRANSACTION SYNERGIS HOLDINGS LIMITED

*

(Incorporated in Bermuda with limited liability)

(Stock Code: 02340) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION

Reference is made to the joint announcements made by Hsin Chong Construction Group

Ltd. ("Hsin Chong") and Synergis Holdings Limited ("Synergis") dated 10 September

2012, 27 September 2012 and 30 November 2012, and the respective circulars of Hsin Chong and Synergis dated 26 October 2012 (the "Circulars"), in relation to, among others, the re-alignment of business interests between Hsin Chong and Synergis, and the general business services agreement renewed by Hsin Chong and Synergis. Unless otherwise stated, terms defined in the Circulars shall have the same meanings as those used in this joint announcement.

The respective boards of directors of Hsin Chong and Synergis are pleased to announce that base upon the management accounts, the Actual Profit exceeds HK$30 million. Synergis will therefore issue 21,333,333 Bonus Convertible Preference Shares within 30 Business Days of the date of the Guarantee Certificate to be issued in accordance with the Sale and Purchase Agreement.

By order of the board of directors of

Hsin Chong Construction Group Ltd. Wilfred WONG Ying-wai

Chairman and Chief Executive Officer

Hong Kong, 22 March 2013

By order of the board of directors of

Synergis Holdings Limited Fan Cheuk Hung

Managing Director
This joint announcement is available for viewing on the Stock Exchange's website: http://www.hkex.com.hk and the websites of Hsin Chong: http://www.hsinchong.com and Synergis: http://www.synergis.com.hk respectively.
As at the date of this joint announcement, the board of Hsin Chong comprises Mr. Wilfred WONG Ying-wai (chairman and chief executive officer), Dr. Catherine CHU, Dr. Barry John BUTTIFANT and Mr. Joseph CHOI Kin-hung as executive directors; Dr. Kenneth CHU Ting-kin as non-executive director; and Hon. Jeffrey LAM Kin-fung, Hon. Abraham SHEK Lai-him and Mr. Alexander MAK Kwai-wing as independent non-executive directors.
As at the date of this joint announcement, the board of Synergis comprises Mr. Wilfred Wong Ying Wai (chairman), Dr. Fan Cheuk Hung (managing director) and Dr. Catherine Chu as executive directors; Mr. Tenniel Chu and Dr. Barry John Buttifant as non-executive directors; and Mr. Stephen Ip Shu Kwan, Dr. Kan Fook Yee, Mr. Wong Tsan Kwong and Mr. David Yu Hon To as independent non-executive directors.

* for identification purposes only

distributed by
Recommend :
0
React to this article
Latest news
Date Title
<1m ago BRISTOL MYERS SQUIBB : An Application for the Trademark "PRAVIGARD" Has Been Filed by Bristol-Myers Squibb
<1m ago An Application for the Trademark "O Q" Has Been Filed by Pfizer
<1m ago An Application for the Trademark "JUSTRION" Has Been Filed by Gilead Sciences
<1m ago An Application for the Trademark "JURAVE" Has Been Filed by GlaxoSmithKline
<1m ago INTELLICELL BIOSCIENCES : An Application for the Trademark "INTELLICELL" Has Been Filed by IntelliCell BioSciences
<1m ago An Application for the Trademark "MYALLIPLAN" Has Been Filed by GlaxoSmithKline
<1m ago BRISTOL MYERS SQUIBB : An Application for the Trademark "LATRABA" Has Been Filed by Bristol-Myers Squibb
<1m ago An Application for the Trademark "IVLONYM" Has Been Filed by GlaxoSmithKline
<1m ago BRISTOL MYERS SQUIBB : An Application for the Trademark "JENPATA" Has Been Filed by Bristol-Myers Squibb
<1m ago An Application for the Trademark "KING PHARMACEUTICALS" Has Been Filed by Pfizer
Latest news
Advertisement
Hot News 
TUBEMOGUL : Nasdaq stocks posting largest percentage increases
ASOS : Steff's Mom Shorts
FOXTONS : Property Foxtons predicts house market slowdown
RAVEN RUSSIA : Half Yearly Report
SPEEDWAY : Michigan International Speedway Continues on Track to a Greener Michigan, Powered by Consumers Energy
Most Read News
1d ago HILLSHIRE BRANDS : Tyson wins U.S. Justice Dept antitrust nod for Hillshire deal
1d ago KRATON PERFORMANCE POLYMERS : to Present at the 2014 RBC Capital Markets' Industrials Conference
1d ago VMWARE USER GROUP : (VMUG) Announces 100,000-Member Milestone
1d ago OAK HILL CAPITAL MAY SEEK SMALLER BUYOUT FUND : sources
1d ago CANADIAN WESTERN BANK : CWB Reports Record Quarterly Earnings
Most recommended articles
2m ago DEUTSCHE LUFTHANSA : Pilots at Lufthansa's Germanwings to walk out on Friday: union
9m ago EUR/USD TECHNICAL ANALYSIS : Recovery to Yield Short Setup
9m ago USD/JPY TECHNICAL ANALYSIS : Weakness Signaled Below 105.00
18m ago Qantas looks past record loss, opens door to foreign investors
24m ago GBP/USD TECHNICAL ANALYSIS : Pound Gears Up for Recovery
Dynamic quotes  
ON
| OFF